These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33795005)

  • 1. Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice.
    Ali T; Hannaoui S; Nemani S; Tahir W; Zemlyankina I; Cherry P; Shim SY; Sim V; Schaetzl HM; Gilch S
    Acta Neuropathol Commun; 2021 Apr; 9(1):58. PubMed ID: 33795005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz.
    Mast N; Li Y; Pikuleva IA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.
    Petrov AM; Mast N; Li Y; Pikuleva IA
    FASEB J; 2019 Aug; 33(8):8782-8798. PubMed ID: 31063705
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
    J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.
    Mast N; Saadane A; Valencia-Olvera A; Constans J; Maxfield E; Arakawa H; Li Y; Landreth G; Pikuleva IA
    Neuropharmacology; 2017 Sep; 123():465-476. PubMed ID: 28655608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice.
    Mast N; Li Y; Linger M; Clark M; Wiseman J; Pikuleva IA
    J Biol Chem; 2014 Feb; 289(6):3529-38. PubMed ID: 24352658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.
    Rubenstein R; Chang B
    PLoS One; 2013; 8(7):e66352. PubMed ID: 23843953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.
    Petrov AM; Lam M; Mast N; Moon J; Li Y; Maxfield E; Pikuleva IA
    Neurotherapeutics; 2019 Jul; 16(3):710-724. PubMed ID: 31062296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro.
    Mast N; Fotinich A; Pikuleva IA
    Drug Metab Dispos; 2022 Jul; 50(7):923-930. PubMed ID: 35489779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
    Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
    J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-Dihydroxy Metabolite.
    Mast N; Li Y; Pikuleva IA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
    Anderson KW; Mast N; Hudgens JW; Lin JB; Turko IV; Pikuleva IA
    J Biol Chem; 2016 May; 291(22):11876-86. PubMed ID: 27056331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.
    Mast N; Verwilst P; Wilkey CJ; Guengerich FP; Pikuleva IA
    J Med Chem; 2020 Jun; 63(12):6477-6488. PubMed ID: 31617715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.
    Wadia JS; Schaller M; Williamson RA; Dowdy SF
    PLoS One; 2008; 3(10):e3314. PubMed ID: 19390657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
    Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
    Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
    J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum.
    Campana V; Sarnataro D; Fasano C; Casanova P; Paladino S; Zurzolo C
    J Cell Sci; 2006 Feb; 119(Pt 3):433-42. PubMed ID: 16443748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.